HighVista Strategies LLC

Position in GHRS — GH Research PLC

CIK 1335325 BOSTON, MA

Position in GHRS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,267,737

+$1,269,977 QoQ

Shares Held

158,770

-25.5% QoQ

Ownership

0.231%

of shares outstanding

% of Portfolio

0.98%

of 13F equity value

Holder Rank

#16

of 62 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. GHRS ranks #25 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,267,737	158,770	-25.5%	Shares	Sole	2026-08-14
2026-03-31	$2,997,760	213,212	-11.4%	Shares	Sole	2026-05-15
2025-12-31	$3,054,654	240,524	-0.6%	Shares	Sole	2026-02-17
2025-09-30	$3,459,084	241,894	+363.0%	Shares	Sole	2025-11-14
2025-06-30	$636,890	52,247	-20.4%	Shares	Sole	2025-08-14
2022-12-31	$637,602	65,597	+15.6%	Shares	Sole	2023-02-14
2022-09-30	$659,655	56,769	-11.2%	Shares	Sole	2022-11-14
2022-06-30	$638,081	63,936	+21.0%	Shares	Sole	2022-08-15
2022-03-31	$966,443	52,840	+95.6%	Shares	Sole	2022-05-16
2021-12-31	$630,143	27,010	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.